1. 58PPharmacokinetics of ZR2002, a combi-molecule with EGFR and DNA-damaging properties and its efficacy in an orthotopic glioblastoma mouse model. (5th March 2018) Authors: Sharifi, Z; Meehan, B; Daniel, P; Eppert, K; Jean-Claude, B; Rak, J; Abdulkarim, B; Sabri, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dual‐role FilmArray® diagnostics for high‐impact viral diseases. Issue 3 (March 2016) Authors: Dorsch, M; Meehan, B; Michalski, WP; Heine, HG; Foord, AJ; Carlile, G; Wang, J; McCullough, S; Zuelke, K Journal: Australian veterinary journal Issue: Volume 94:Issue 3(2016) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-044 Mucosa-Associated E.coli Isolates from Inflammatory Bowel Disease and Colorectal Cancer Patients Activate Wnt/Beta-Catenin Signalling in vitro and in vivo. (17th August 2016) Authors: Meehan, B; Campbell, BJ; Rhodes, JM Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PWE-347 Adherent, invasive mucosa-associated e. coli isolates from colorectal cancer patients activate WNT signalling. (22nd June 2015) Authors: Meehan, B; Campbell, B; Rhodes, J Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗